Catecholaminergic regulation of venous function in the rainbow trout.
The significance of the sympathetic nervous system (SNS) in regulating peripheral vascular resistance and cardiac function in fish has been well established, whereas its effect on venous function in vivo is unknown. Two protocols were employed in the present study to evaluate SNS effects on the venous system in intact, unanesthetized trout. In the first, trout were instrumented with pressure cannulas in the ventral (PVA) and dorsal (PDA) aortas and ductus Cuvier (PVEN), and cardiac output (CO) was measured with a flow probe around the ventral aorta. Heart rate, stroke volume, and gill and systemic resistances were calculated from the measured parameters. In the second group, vascular capacitance curves were obtained by monitoring mean circulatory filling pressure (PVEN) during transient interruption of CO and while blood volume was adjusted between 80 and 120% of normal. Unstressed blood volume (USBV) and vascular compliance (C) were derived from the capacitance curves. Infusion of epinephrine (Epi; 3.3 nmol.min-1.kg body wt-1) increased PVA, PDA, and PVEN, whereas norepinephrine (NE) infusion (3.3 nmol.min-1.kg body wt-1) increased PVA and PDA but did not affect PVEN. Epi (1.0 nmol.min-1.kg body wt-1), but not NE (2.6 or 10.4 nmol.min-1.kg body wt-1), displaced the capacitance curve to the right and significantly decreased USBV. Inhibition of alpha 1-adrenoceptors with prazosin, or ganglionic nicotinic receptor blockade with hexamethonium, produced a left shift in the capacitance curve, and both treatments increased USBV and C. Conversely, the alpha-adrenoceptor antagonist phentolamine did not effect vascular capacitance. These results show that Epi has potent effects on trout veins in vivo and that it mobilizes blood from the unstressed into the stressed vascular compartment and augments central venous pressure by decreasing venous compliance. These results also show that the SNS is an active effector of venous tone and compliance in trout; this is the first demonstration of tonic regulation of vascular capacitance in any fish.
Zhang
Y
Y
Indiana University School of Medicine, South Bend Center for Medical Education, University of Notre Dame 46556, USA.
Weaver
L
L
Ibeawuchi
A
A
Olson
K R
KR
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000502:physiology; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D018738:Hexamethonium / Q000494:pharmacology; D008297:Male; D018733:Nicotinic Antagonists / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D017686:Oncorhynchus mykiss / Q000502:physiology*; D010646:Phentolamine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D018924:Vascular Capacitance / Q000187:drug effects; D014680:Veins / Q000187:drug effects*
D005730:Ganglionic Blockers; D018733:Nicotinic Antagonists; D013565:Sympatholytics; D018738:Hexamethonium; D009638:Norepinephrine; D011224:Prazosin; D004837:Epinephrine; D010646:Phentolamine